Liver Diseases  >>  Selzentry (maraviroc)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Selzentry (maraviroc) / ViiV Healthcare
NCT00782301: Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Withdrawn
4
0
US, Canada, Europe
maraviroc, Selzentry, etravirine
ViiV Healthcare, Pfizer
Hepatitis B, Human Immunodeficiency Virus, Hepatitis C, Chronic
02/10
02/10
NCT01327547 / 2010-021994-35: A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Completed
4
138
US, Europe, RoW
Maraviroc, Selzentry, Celsentri, Placebo
ViiV Healthcare, Pfizer
HIV Coinfection
04/13
03/15

Download Options